Quantcast

Tag Archives: Neurontin

Rulings give lawyers roadmap for suing drug makers for marketing fraud

In the first ruling of its kind, a federal appeals court upheld a $142 million jury verdict against drug maker Pfizer for fraudulent marketing based on statistical evidence that its marketing campaign caused doctors to prescribe epilepsy drug Neurontin for ...

Read More »

Pfizer must pay $142M over Neurontin marketing

Drug maker Pfizer violated the Racketeer Influenced and Corrupt Organizations Act by engaging in a fraudulent marketing scheme promoting the epilepsy drug Neurontin for “off-label” uses, the 1st U.S. Circuit Court of Appeals has ruled in affirming judgment.

Read More »

Drug litigation in review 2010

Much like 2009, 2010 was a busy year for prescription drug suits.

Read More »